Respiratory

Presenters at CHEST 2020 discussed the concept of how patients with interstitial lung disease (ILD) can develop a progressive fibrosis phenotype and how providers can detect and treat these patients.

Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease 2019 vaccine, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.

Ransomware attacks threaten US hospitals; the Trump administration purchases 300,000 doses of an antibody drug; CMS releases coverage plan for COVID-19 vaccine and treatments.

Depression and anxiety in pregnant women may disrupt fetal lung development, leading to an increased incidence of asthma and respiratory symptoms in their children.

Maryland’s coronavirus disease 2019 (COVID-19) task force on vulnerable populations leveraged data on social determinants of health to rapidly pinpoint populations most at risk of severe COVID-19 complications.

Study results from a phase 1 trial looking at 2 RNA-based severe acute respiratory syndrome coronavirus 2 vaccine candidates give further insight into the candidates’ safety profiles.

The United States has its first reported of coronavirus disease 2019 (COVID-19) reinfection, in a young male patient with no underlying immune conditions.

The Trump administration signed a $486 million agreement with AstraZeneca to develop a coronavirus disease 2019 (COVID-19) antibody treatment.

Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.

About 3 days after being airlifted to the hospital to be treated for symptoms stemming from coronavirus disease 2019 (COVID-19) infection, the president is returning to the White House.

During a 1-hour free webinar from MJH Life Sciences™’s COVID-19 Coalition, experts discussed various myths around the coronavirus disease 2019 (COVID-19) pandemic.

There were a myriad of factors considered when deciding how to reopen higher education institutions amid the COVID-19 pandemic, particularly in prioritizing the safety of students, faculty, and community members, as well as the quality of education delivered.

The study is part of Moderna’s larger trial to find a vaccine to prevent coronavirus disease 2019, which puts older adults, who have weaker immune responses, at a higher risk of more severe illness and death.

HHS said it will send 100 million rapid COVID-19 tests to states by year’s end; CDC says teens twice as likely to get coronavirus infection than young children; several private health insurers to stop waiving telehealth copays.

Almost as fast as coronavirus disease 2019 (COVID-19) spread around the world, so has misinformation about the infectious disease. MJH Life Sciences™ will host a free webinar to get the facts from the experts.

By taking part in a coronavirus disease 2019 (COVID-19) vaccine trial, participants can provide their personalized experience, which may help protect future generations of similar race and socioeconomic background.

The CDC abruptly pulled guidance saying that COVID-19 is primarily spread via airborne transmission; HHS issues memo stating that the FDA no longer has the authority to sign any new rules on food, vaccines; a novel study examines risk of infection during a flight.

Implementing a multidisciplinary discussion has positive implications for both the diagnosis and management of interstitial lung disease (ILD), according to study findings.

As smoke from West Coast wildfires threatens to worsen outdoor air quality across the country, concerns of indoor air quality are mounting following reports on how insufficient ventilation systems facilitate aerosol spread of COVID-19.

Researchers wanted to see if children with a certain allele benefitted from receiving montelukast instead of long-acting beta-2 agonist/inhaled corticosteroid therapy.

While coronavirus disease 2019 (COVID-19) is largely a respiratory disease, it is actually a systemic disease that has a wide range of effects and postinfection sequelae that aren’t yet fully known, said Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

For patients with systemic sclerosis, myopathy is a risk factor for worse outcomes and survival, according to a recent study.

Nineteen bioethicists proposed a 3-phase plan for equitable distribution of a vaccine for coronavirus disease 2019 (COVID-19).

President Donald Trump promised a coronavirus disease 2019 (COVID-19) vaccine by the end of the year; COVID-19 survivors report anxiety over reinfection; colleges release COVID-19 testing and quarantine data.

Preliminary data find Moderna's COVID-19 vaccine effective in older adults; FDA authorizes use of $5 COVID-19 rapid test; the DOJ asks for nursing home data from 4 blue states.